$CPHD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CEPHEID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CEPHEID. Get notifications about new insider transactions in CEPHEID for free.
Page: < prev 1 ... 10 11 12 13 14 15 16 17 18 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 37.17 | 467 | 17,358 | 5,756 | 6.2 K to 5.8 K (-7.50 %) |
Apr 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,000 | 0 | 6,223 | 5.2 K to 6.2 K (+19.15 %) |
Apr 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
Apr 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 0.00 | 1,050 | 0 | 89,125 | 88.1 K to 89.1 K (+1.19 %) |
Apr 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 36.05 | 3,000 | 108,156 | 752,300 | 755.3 K to 752.3 K (-0.40 %) |
Apr 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Apr 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | A | 35.72 | 22,500 | 803,700 | 22,500 | |
Apr 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Apr 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 37.17 | 467 | 17,358 | 6,306 | 6.8 K to 6.3 K (-6.90 %) |
Apr 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 1,000 | 0 | 6,773 | 5.8 K to 6.8 K (+17.32 %) |
Apr 26 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Option Exercise | M | 0.00 | 700 | 0 | 1,400 | |
Apr 26 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Buy | M | 0.00 | 700 | 0 | 1,217 | 517 to 1.2 K (+135.40 %) |
Apr 26 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
Apr 26 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 0.00 | 1,050 | 0 | 76,123 | 75.1 K to 76.1 K (+1.40 %) |
Apr 26 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
Apr 26 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Buy | M | 0.00 | 1,050 | 0 | 18,759 | 17.7 K to 18.8 K (+5.93 %) |
Apr 26 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
Apr 26 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 0.00 | 1,050 | 0 | 7,600 | 6.6 K to 7.6 K (+16.03 %) |
Apr 26 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
Apr 26 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Buy | M | 0.00 | 1,050 | 0 | 14,600 | 13.6 K to 14.6 K (+7.75 %) |
Apr 26 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | M | 0.00 | 1,050 | 0 | 0 | |
Apr 26 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | A | 35.72 | 9,375 | 334,875 | 9,375 | |
Apr 26 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | A | 0.00 | 1,050 | 0 | 1,050 | |
Apr 26 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Buy | M | 0.00 | 1,050 | 0 | 182,434 | 181.4 K to 182.4 K (+0.58 %) |
Apr 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Apr 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | A | 35.72 | 48,750 | 1,741,350 | 48,750 | |
Apr 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 | |
Apr 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 37.17 | 467 | 17,358 | 2,036 | 2.5 K to 2 K (-18.66 %) |
Apr 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 1,000 | 0 | 2,503 | 1.5 K to 2.5 K (+66.53 %) |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 4,553 | 19,578 | 22,191 | |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 18,821 | 80,930 | 26,744 | |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 44.50 | 4,553 | 202,609 | 5,773 | 10.3 K to 5.8 K (-44.09 %) |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 4,553 | 19,578 | 10,326 | 5.8 K to 10.3 K (+78.87 %) |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 44.00 | 8,800 | 387,200 | 5,773 | 14.6 K to 5.8 K (-60.39 %) |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 43.50 | 8,800 | 382,800 | 14,573 | 23.4 K to 14.6 K (-37.65 %) |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 43.00 | 1,221 | 52,503 | 23,373 | 24.6 K to 23.4 K (-4.96 %) |
Mar 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 18,821 | 80,930 | 24,594 | 5.8 K to 24.6 K (+326.02 %) |
Mar 28 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 43.59 | 1,800 | 78,464 | 755,300 | 757.1 K to 755.3 K (-0.24 %) |
Mar 28 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 43.11 | 1,200 | 51,730 | 757,100 | 758.3 K to 757.1 K (-0.16 %) |
Mar 21 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 7,579 | 32,590 | 45,565 | |
Mar 21 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 43.00 | 7,579 | 325,897 | 5,773 | 13.4 K to 5.8 K (-56.76 %) |
Mar 21 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 7,579 | 32,590 | 13,352 | 5.8 K to 13.4 K (+131.28 %) |
Mar 08 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 26,400 | 113,520 | 61,944 | |
Mar 08 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 41.00 | 8,800 | 360,800 | 5,773 | 14.6 K to 5.8 K (-60.39 %) |
Mar 08 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 42.00 | 8,800 | 369,600 | 14,573 | 23.4 K to 14.6 K (-37.65 %) |
Mar 08 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 41.50 | 8,800 | 365,200 | 23,373 | 32.2 K to 23.4 K (-27.35 %) |
Mar 08 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 26,400 | 113,520 | 32,173 | 5.8 K to 32.2 K (+457.30 %) |
Mar 13 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 8,800 | 37,840 | 53,144 | |
Mar 13 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 42.50 | 8,800 | 374,000 | 5,773 | 14.6 K to 5.8 K (-60.39 %) |
Mar 13 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 8,800 | 37,840 | 14,573 | 5.8 K to 14.6 K (+152.43 %) |
Feb 28 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 41.70 | 3,000 | 125,086 | 758,300 | 761.3 K to 758.3 K (-0.39 %) |
Feb 14 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 4,196 | 15,148 | 6,604 | |
Feb 14 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 32.50 | 4,196 | 136,370 | 18,373 | 22.6 K to 18.4 K (-18.59 %) |
Feb 14 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 4,196 | 15,148 | 22,569 | 18.4 K to 22.6 K (+22.84 %) |
Feb 14 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 42.16 | 263 | 11,088 | 517 | 254 to 517 (+103.54 %) |
Feb 14 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 42.16 | 287 | 12,100 | 75,073 | 74.8 K to 75.1 K (+0.38 %) |
Feb 14 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 33.61 | 360 | 12,100 | 74,786 | 74.4 K to 74.8 K (+0.48 %) |
Feb 14 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 31.92 | 379 | 12,098 | 74,426 | 74 K to 74.4 K (+0.51 %) |
Feb 14 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 31.50 | 371 | 11,687 | 74,047 | 73.7 K to 74 K (+0.50 %) |
Feb 14 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 42.16 | 382 | 16,105 | 181,384 | 181 K to 181.4 K (+0.21 %) |
Feb 14 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 42.16 | 358 | 15,093 | 17,709 | 17.4 K to 17.7 K (+2.06 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 20,000 | 147,600 | 30,000 | |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 26,750 | 197,415 | 5,000 | |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 44.49 | 10,000 | 444,900 | 1,413 | 11.4 K to 1.4 K (-87.62 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 44.43 | 400 | 17,770 | 11,413 | 11.8 K to 11.4 K (-3.39 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 43.52 | 9,600 | 417,811 | 11,813 | 21.4 K to 11.8 K (-44.83 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 43.06 | 26,750 | 1,151,882 | 21,413 | 48.2 K to 21.4 K (-55.54 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 46,750 | 345,015 | 48,163 | 1.4 K to 48.2 K (+3,308.56 %) |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 20.47 | 17,062 | 349,259 | 21,938 | |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 8.43 | 9,375 | 79,031 | 15,625 | |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 19.85 | 8,270 | 164,160 | 3,750 | |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 19.85 | 2,980 | 59,153 | 12,020 | |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Sell | S | 42.56 | 34,707 | 1,477,234 | 1,021 | 35.7 K to 1 K (-97.14 %) |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 20.47 | 17,062 | 349,259 | 35,728 | 18.7 K to 35.7 K (+91.41 %) |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 8.43 | 9,375 | 79,031 | 18,666 | 9.3 K to 18.7 K (+100.90 %) |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 19.85 | 8,270 | 164,160 | 9,291 | 1 K to 9.3 K (+809.99 %) |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Sell | S | 44.10 | 2,980 | 131,406 | 1,021 | 4 K to 1 K (-74.48 %) |
Feb 09 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 19.85 | 2,980 | 59,153 | 4,001 | 1 K to 4 K (+291.87 %) |
Feb 06 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 8.65 | 7,500 | 64,875 | 0 | |
Feb 06 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 11.85 | 12,500 | 148,125 | 0 | |
Feb 06 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Sell | S | 43.13 | 2,500 | 107,825 | 6,550 | 9.1 K to 6.6 K (-27.62 %) |
Feb 06 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 8.65 | 7,500 | 64,875 | 9,050 | 1.6 K to 9.1 K (+483.87 %) |
Feb 06 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Sell | S | 43.20 | 12,500 | 539,988 | 1,550 | 14.1 K to 1.6 K (-88.97 %) |
Feb 06 2012 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 11.85 | 12,500 | 148,125 | 14,050 | 1.6 K to 14.1 K (+806.45 %) |
Feb 06 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | M | 7.35 | 7,500 | 55,125 | 0 | |
Feb 06 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Sell | S | 43.25 | 7,500 | 324,398 | 13,550 | 21.1 K to 13.6 K (-35.63 %) |
Feb 06 2012 | CPHD | CEPHEID | MORTON DEAN O | Director | Buy | M | 7.35 | 7,500 | 55,125 | 21,050 | 13.6 K to 21.1 K (+55.35 %) |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 20.47 | 20,312 | 415,787 | 28,438 | |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 8.43 | 43,333 | 365,297 | 21,667 | |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 19.85 | 70,312 | 1,395,693 | 4,688 | |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Sell | S | 43.20 | 133,957 | 5,787,478 | 12,841 | 146.8 K to 12.8 K (-91.25 %) |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 8.43 | 43,333 | 365,297 | 146,798 | 103.5 K to 146.8 K (+41.88 %) |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 19.85 | 70,312 | 1,395,693 | 103,465 | 33.2 K to 103.5 K (+212.08 %) |
Feb 06 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 20.47 | 20,312 | 415,787 | 33,153 | 12.8 K to 33.2 K (+158.18 %) |
Feb 06 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 9.94 | 15,000 | 149,100 | 0 | |
Feb 06 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 43.09 | 15,000 | 646,350 | 88,075 | 103.1 K to 88.1 K (-14.55 %) |
Feb 06 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 9.94 | 15,000 | 149,100 | 103,075 | 88.1 K to 103.1 K (+17.03 %) |
Feb 06 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | M | 10.06 | 15,000 | 150,900 | 0 | |
Feb 06 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Sell | S | 43.20 | 15,000 | 648,030 | 17,351 | 32.4 K to 17.4 K (-46.37 %) |
Feb 06 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Buy | M | 10.06 | 15,000 | 150,900 | 32,351 | 17.4 K to 32.4 K (+86.45 %) |
Feb 06 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 6,887 | 24,862 | 0 | |
Feb 06 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 43.51 | 6,887 | 299,646 | 20,432 | 27.3 K to 20.4 K (-25.21 %) |
Feb 06 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 6,887 | 24,862 | 27,319 | 20.4 K to 27.3 K (+33.71 %) |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 20.47 | 5,687 | 116,413 | 21,938 | |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 8.43 | 4,213 | 35,516 | 12,500 | |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 8.43 | 3,287 | 27,709 | 16,713 | |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 21.00 | 48,875 | 1,026,375 | 12,500 | |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 43.16 | 9,900 | 427,264 | 5,223 | 15.1 K to 5.2 K (-65.46 %) |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 20.47 | 5,687 | 116,413 | 15,123 | 9.4 K to 15.1 K (+60.27 %) |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 8.43 | 4,213 | 35,516 | 9,436 | 5.2 K to 9.4 K (+80.66 %) |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 43.15 | 52,162 | 2,250,842 | 5,223 | 57.4 K to 5.2 K (-90.90 %) |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 8.43 | 3,287 | 27,709 | 57,385 | 54.1 K to 57.4 K (+6.08 %) |
Feb 06 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 21.00 | 48,875 | 1,026,375 | 54,098 | 5.2 K to 54.1 K (+935.76 %) |
Jan 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 312 | 0 | 2,813 | |
Jan 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 43.14 | 131 | 5,651 | 5,125 | 5.3 K to 5.1 K (-2.49 %) |
Jan 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 312 | 0 | 5,256 | 4.9 K to 5.3 K (+6.31 %) |
Feb 06 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 14.93 | 40,000 | 597,200 | 130,000 | |
Feb 06 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Sell | S | 43.11 | 40,000 | 1,724,376 | 1,503 | 41.5 K to 1.5 K (-96.38 %) |
Feb 06 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 14.93 | 40,000 | 597,200 | 41,503 | 1.5 K to 41.5 K (+2,661.34 %) |
Jan 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 338 | 0 | 3,047 | |
Jan 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 43.14 | 142 | 6,126 | 12,841 | 13 K to 12.8 K (-1.09 %) |
Jan 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 338 | 0 | 12,983 | 12.6 K to 13 K (+2.67 %) |
Jan 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 3,047 | |
Jan 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 43.14 | 142 | 6,126 | 1,413 | 1.6 K to 1.4 K (-9.13 %) |
Jan 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 1,555 | 1.2 K to 1.6 K (+27.77 %) |
Jan 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 11,250 | |
Jan 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 43.14 | 524 | 22,605 | 2,723 | 3.2 K to 2.7 K (-16.14 %) |
Jan 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 3,247 | 2 K to 3.2 K (+62.59 %) |
Jan 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 271 | 0 | 2,437 | |
Jan 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 43.14 | 114 | 4,918 | 1,021 | 1.1 K to 1 K (-10.04 %) |
Jan 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 271 | 0 | 1,135 | 864 to 1.1 K (+31.37 %) |
Jan 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 11,250 | |
Jan 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 43.14 | 523 | 22,562 | 20,432 | 21 K to 20.4 K (-2.50 %) |
Jan 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 20,955 | 19.7 K to 21 K (+6.34 %) |
Jan 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 32.14 | 3,000 | 96,412 | 761,300 | 764.3 K to 761.3 K (-0.39 %) |
Jan 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 344 | 0 | 3,094 | |
Jan 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 43.14 | 145 | 6,255 | 1,503 | 1.6 K to 1.5 K (-8.80 %) |
Jan 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 344 | 0 | 1,648 | 1.3 K to 1.6 K (+26.38 %) |